{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:13:13Z","timestamp":1791583993184,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011096","name":"Philippine Council for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007679","name":"Open Source Drug Discovery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007224","name":"National Foundation for Science and Technology Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Southeast Asia"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.lansea.2024.100464","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T05:08:14Z","timestamp":1723784894000},"page":"100464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Drug development in LMICs: could the emerging Indian model usher the southeast Asian region?"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4137-4482","authenticated-orcid":false,"given":"Bharat","family":"Pant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3915-8927","authenticated-orcid":false,"given":"Jayant","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6348-6667","authenticated-orcid":false,"given":"Vikram","family":"Gota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lansea.2024.100464_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/tp.tp_48_21","article-title":"Brahmachari and his battle against Kala-Azar","volume":"11","author":"Saha","year":"2021","journal-title":"Trop Parasitol"},{"issue":"7","key":"10.1016\/j.lansea.2024.100464_bib3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/ml500183c","article-title":"Drug discovery research in India: current state and future prospects","volume":"5","author":"Balganesh","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.lansea.2024.100464_bib4","series-title":"R&D for development of new drugs for neglected diseases: how can India contribute","author":"Chaudhuri","year":"2005"},{"key":"10.1016\/j.lansea.2024.100464_bib5","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0150","article-title":"Delivering vaccines to the people who need them most","volume":"370","author":"Barocchi","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.lansea.2024.100464_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/bmj.39301.420012.DB","article-title":"Court dismisses Novartis challenge to Indian patent\u00a0law","volume":"335","author":"Mudur","year":"2007","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.lansea.2024.100464_bib7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/jwip.12267","article-title":"Lessons from India and Thailand for Cambodia's future implementation of the TRIPS agreement for pharmaceutical patents","volume":"26","author":"Tenni","year":"2023","journal-title":"J\u00a0World Intellect Prop"},{"key":"10.1016\/j.lansea.2024.100464_bib8","series-title":"Indonesia has potential to be SEA's pharmaceutical industry center","author":"Kurmala","year":"2023"},{"issue":"23","key":"10.1016\/j.lansea.2024.100464_bib9","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus chemotherapy in advanced endometrial cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lansea.2024.100464_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/EDBK_10033","article-title":"Drug development in low- and middle-income countries: opportunity or exploitation?","volume":"42","author":"Jalali","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"50","key":"10.1016\/j.lansea.2024.100464_bib11","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1016\/j.vaccine.2018.01.001","article-title":"Status of vaccine research and development for Helicobacter pylori","volume":"37","author":"Sutton","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.lansea.2024.100464_bib12","article-title":"Surgical staging of locally advanced cervical cancer: current status and research progress","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.lansea.2024.100464_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1513\/AnnalsATS.201209-075PS","article-title":"How academia and the pharmaceutical industry can work together: the president's lecture, annual meeting of the American thoracic society, San Francisco, California","volume":"10","author":"Rosenblatt","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.lansea.2024.100464_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030373","article-title":"Scoping review to map evidence on mechanism of action, pharmacokinetics, effectiveness and side effects of centchroman as a contraceptive pill","volume":"9","author":"Kabra","year":"2019","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.lansea.2024.100464_bib16","first-page":"48","article-title":"A\u00a0randomized, controlled, phase III clinical trial to evaluate the efficacy and tolerability of risorine with conventional rifampicin in the treatment of newly diagnosed pulmonary tuberculosis patients","volume":"65","author":"Patel","year":"2017","journal-title":"J\u00a0Assoc Physicians India"},{"issue":"10317","key":"10.1016\/j.lansea.2024.100464_bib18","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(21)02000-6","article-title":"Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial","volume":"398","author":"Ella","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.lansea.2024.100464_bib20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/d41586-024-00809-y","article-title":"Cutting-edge CAR-T cancer therapy is now made in India \u2014 at one-tenth the cost","volume":"627","author":"Mallapaty","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.lansea.2024.100464_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.freeradbiomed.2019.09.009","article-title":"Oral administration of 3,3\u2019-diselenodipropionic acid prevents thoracic radiation induced pneumonitis in mice by suppressing NF-kB\/IL-17\/G-CSF\/neutrophil axis","volume":"145","author":"Gandhi","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.lansea.2024.100464_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2021.08.017","article-title":"3,3\u2019-Diselenodipropionic acid (DSePA) induces reductive stress in A549 cells triggering p53-independent apoptosis: a novel mechanism for diselenides","volume":"175","author":"Gandhi","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.lansea.2024.100464_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101909","article-title":"Preclinical evaluation of engineered L-asparaginase variants to improve the treatment of Acute Lymphoblastic Leukemia","volume":"43","author":"Sengupta","year":"2024","journal-title":"Transl Oncol"},{"key":"10.1016\/j.lansea.2024.100464_bib24","series-title":"Bethesda (MD): U.S. National library of medicine; 2000- .identifier NCT05348239, A phase II study to evaluate oral chlorophyllin in hemorrhagic cystitis secondary to radiation therapy for pelvic malignancies","year":"2022"},{"issue":"3","key":"10.1016\/j.lansea.2024.100464_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30813","article-title":"Bioequivalence study followed by model-informed dose optimization of a powder for oral suspension of 6-mercaptopurine","volume":"71","author":"Arun","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.lansea.2024.100464_bib27","series-title":"Forming meaningful pharma\u2013academia partnerships","author":"Vratsanos","year":"2023"},{"key":"10.1016\/j.lansea.2024.100464_bib28","author":"Harachand"},{"key":"10.1016\/j.lansea.2024.100464_bib29","series-title":"ICMR set to develop centres for phase I clinical trial","author":"Yadav","year":"2022"},{"issue":"10","key":"10.1016\/j.lansea.2024.100464_bib30","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2174\/1568026611313100005","article-title":"Open source software and web services for designing therapeutic molecules","volume":"13","author":"Singla","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.lansea.2024.100464_bib31","series-title":"Veronica vargas: south-to-south collaboration and south asia's role in vaccine R&D","year":"2005"},{"issue":"6","key":"10.1016\/j.lansea.2024.100464_bib32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S2468-1253(21)00031-5","article-title":"Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2\/3 trial","volume":"6","author":"Andrieux-Meyer","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.lansea.2024.100464_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cid\/ciab864","article-title":"Three-year efficacy and safety of takeda's dengue vaccine candidate (TAK-003)","volume":"75","author":"Rivera","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.lansea.2024.100464_bib34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s11101-014-9335-7","article-title":"Investigation of Vietnamese plants for potential anticancer agents","volume":"13","author":"P\u00e9rez","year":"2014","journal-title":"Phytochem Rev"},{"key":"10.1016\/j.lansea.2024.100464_bib35","article-title":"Regional and international collaboration: key to quality research in south Asia","volume":"9","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/j.lansea.2024.100464_bib36","series-title":"Signing ceremony of strategic collaboration on developing and discovering new drugs - pharmacy of school of medicine - Vietnam national university Ho Chi Minh City","year":"2023"},{"issue":"2","key":"10.1016\/j.lansea.2024.100464_bib37","article-title":"Triple helix collaboration in Indonesia's Covid-19 vaccine development: understanding the barriers and enablers","volume":"6","author":"Jatraningrum","year":"2021","journal-title":"STI Pol Manag J"},{"issue":"4","key":"10.1016\/j.lansea.2024.100464_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wmh3.440","article-title":"Assessment of country readiness for drug development: a qualitative study in Indonesia","volume":"13","author":"Siagian","year":"2021","journal-title":"World Med Health Policy"},{"key":"10.1016\/j.lansea.2024.100464_bib39","series-title":"The 13th Asia partnership conference of pharmaceutical associations","year":"2024"},{"key":"10.1016\/j.lansea.2024.100464_bib40","author":"Gaud"},{"issue":"3","key":"10.1016\/j.lansea.2024.100464_bib41","first-page":"900","article-title":"Establishing successful university\u2013industry collaborations: barriers and enablers deconstructed","volume":"48","author":"O'Dwyer","year":"2023","journal-title":"J\u00a0Technol Transf"},{"key":"10.1016\/j.lansea.2024.100464_bib42","series-title":"New drugs and clinical trials Rules","year":"2019"},{"key":"10.1016\/j.lansea.2024.100464_bib43","series-title":"Vietnam's growing pharmaceutical industry: a comprehensive guide for 2022","author":"Nguyen","year":"2022"},{"key":"10.1016\/j.lansea.2024.100464_bib44","series-title":"The future of Vietnam's pharmaceutical industry: unpacked","author":"Shira","year":"2023"},{"key":"10.1016\/j.lansea.2024.100464_bib45","series-title":"Malaysia's clinical research ecosystem","author":"Khalid","year":"2017"},{"key":"10.1016\/j.lansea.2024.100464_bib47","series-title":"Biopharmaceutical industry","year":"2021"},{"key":"10.1016\/j.lansea.2024.100464_bib48","series-title":"After price cap, local stent makers capture 60% of market","author":"Dey","year":"2020"}],"container-title":["The Lancet Regional Health - Southeast Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368224001148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368224001148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:08:49Z","timestamp":1789186129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772368224001148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":42,"alternative-id":["S2772368224001148"],"URL":"https:\/\/doi.org\/10.1016\/j.lansea.2024.100464","relation":{},"ISSN":["2772-3682"],"issn-type":[{"value":"2772-3682","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug development in LMICs: could the emerging Indian model usher the southeast Asian region?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Southeast Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lansea.2024.100464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100464"}}